Editorial Board

Editor-in-Chief

  • Michelle Leech, PhD, MSc, BSc, The University of Dublin Trinity College, Dublin, Ireland, Education and training, Patient information and Advocacy

Editorial Board Members

  • Nigel Anderson, PhD, Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, Australia, Head and neck radiotherapy, with a particular focus on improving practice to minimise the effects of radiation induced complications,   advanced treatment and imaging techniques to improve the quality of radiotherapy across multiple cancer sites,   clinical guidelines for head and neck radiotherapy, inclusive of reactive and prophylactic enteral feeding in definitive (Chemo) IMRT for head-and-neck cancer.
  • Nicolaus Andratschke, MD, University of Zurich, Zurich, Switzerland, Oligometastases,  Reirradiation,  Brain metastases,  Stereotactic radiotherapy
  • Suzanne van Beek, Msc, Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Netherlands,  Image guided adaptive radiation therapy,  Head and Neck,  Library of plans,  plan of the day,  Cone Beam CT
  • Luca Boldrini, MD, University Hospital Agostino Gemelli, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Roma, Italy, Radiation oncology,  MRI guided radiotherapy,  radiomics,  artificial intelligence
  • Mikki Campbell, BSc, MRT(T), MHE, Canadian Association of Medical Radiation Technologists, Ottawa, Ontario, Canada, Advancement of radiation medicine through the integration of novel technologies, Accessibility and delivery of quality patient-centred care, Stereotactic radiation (SRS/SBRT) to brain and spine tumours, Integration of MRI in radiation therapy
  • Luca Capone, PhD, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America, Brain Metastases,  Radiosurgery,  Intensity Modulated Radiation Therapy
  • Mary Coffey, MA, DCR(T),HDCR(T), TDCR(T), The University of Dublin Trinity College, Dublin, Ireland, Radiation Therapy education and risk management
  • Geoffrey P Delaney, MBBS, FRANZCR, MD, PhD, University of New South Wales, Sydney, New South Wales, Australia, Radiotherapy,  Health services research,  Cancer,  Radiotherapy safety,  Breast cancer.
  • Colleen Dickie, MRT(T) (MR), MSc, University Health Network, Toronto, Ontario, Canada, Soft Tissue Sarcoma,  Radiotherapy,  Image Guidance,  Limb immobilization
  • Aileen Duffton, MSc APRO, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom, Image guided RT (IGRT),  Pancreatic cancer,  Stereotactic body RT (SBRT),  Adaptive RT (ART)
  • Sara Faithfull, PhD, MSc, BSc (Hons), RN, University of Surrey, Guildford, United Kingdom, Clinical innovation,   Radiotherapy supportive care
  • Gerry Hanna, MB BCh PhD MRCP(UK) FRCR, Peter MacCallum Cancer Centre, Melbourne, Australia, Lung Cancer,  Radiotherapy,  SABR,  Breast Cancer,  Stereotactic
  • Suneil Jain, MB BCh PhD, Belfast Health and Social Care Trust, Belfast, United Kingdom, Prostate Cancer,  Stereotactic radiotherapy,  Brachytherapy,  Biomarkers,  Nanotechnology
  • Rianne de Jong, PhD, Academic Medical Center, Department of Radiation Oncology, Amsterdam, Netherlands, Online adaptive radiotherapy, Adaptive radiotherapy, Image guided radiotherapy, Conebeam CT, Rectal cancer, Plan selection
  • Sultan Kav, RN, PhD, Baskent University, Department of Nursing, Ankara, Turkey, Patient education, Oncology nursing, Palliative care
  • Pia Krause Møller, MPH, Odense University Hospital, Odense, Denmark, Radiotherapy,  Laryngeal Neoplasms,  Tobacco Smoking,  Radiodermatitis
  • Aidan Leong, MHealSc, BHealSc(Hons), University of Otago, Dunedin, New Zealand, Evidence-based practice,  IGRT,  Treatment planning,  Toxicity management,  Education,  Remote teaching
  • Mirjam Mast, MSc, PhD, Medical Centre Haaglanden Location Antoniushove, Leidschendam, Netherlands, Breast cancer,  IGRT,  breathing adapted RT
  • Helen Anne McNair, PhD, Royal Marsden NHS Foundation Trust, London, United Kingdom, Translation of novel radiotherapy technologies into clinical practice, involving investigating the efficacy and efficiency of intensity modulated radiotherapy and image guided radiotherapy,   deliver radiotherapy using real-time treatment planning, by redeploying the radiotherapy workforce to create an optimal patient pathway
  • Poonam Negi, MSc, Tata Memorial Hospital, Mumbai, India, DIBH, plan of the day bladder cancer, OARs delineation (contouring)
  • Sophie Perryck, BSc, University of Zurich, Zurich, Switzerland, Imaging modalities and image fusions,  to smooth over the delineation process,   MR-guided treatment positioning,   Expiration breath-hold for Stereotactic Body Radiotherapy (SBRT) in liver and abdominal tumours
  • Gillian Prue, PhD, Queen's University Belfast, Belfast, United Kingdom, Living with and beyond cancer,  Supportive care,  Symptom management,  Treatment toxicity
  • Philipp Scherer, Msc, Paris Lodron University of Salzburg, Salzburg, Austria, IGRT and ART,   Positioning and immobilization,   Stereotactic radiotherapy,   Radiotherapy for prostate cancer,   IORT
  • Yat Man Tsang, PhD, Mount Vernon Cancer Centre, Northwood, United Kingdom, Radiographer, Radiation Oncology, Radiotherapy, Advanced Practice
  • Michael Velec, PhD, MRT(T), Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada, Adaptive radiotherapy,  deformable image registration,  dose accumulation,  biomechanical models,  quantification of organ motion
  • Sharon Wong Mei Mei, PhD, CMD, National Cancer Centre Singapore, Singapore, Singapore, Radiation Therapy,  Treatment Planning,  Education,  Medical Dosimetry,  Proton Therapy

Editorial Office